Literature DB >> 18171241

Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.

Nina Singh1, Barbara D Alexander, Olivier Lortholary, Françoise Dromer, Krishan L Gupta, George T John, Ramon del Busto, Goran B Klintmalm, Jyoti Somani, G Marshall Lyon, Kenneth Pursell, Valentina Stosor, Patricia Muñoz, Ajit P Limaye, Andre C Kalil, Timothy L Pruett, Julia Garcia-Diaz, Atul Humar, Sally Houston, Andrew A House, Dannah Wray, Susan Orloff, Lorraine A Dowdy, Robert A Fisher, Joseph Heitman, Marilyn M Wagener, Shahid Husain.   

Abstract

BACKGROUND: The role of serum cryptococcal antigen in the diagnosis and determinants of antigen positivity in solid organ transplant (SOT) recipients with pulmonary cryptococcosis has not been fully defined.
METHODS: We conducted a prospective, multicenter study of SOT recipients with pulmonary cryptococcosis during 1999-2006.
RESULTS: Forty (83%) of 48 patients with pulmonary cryptococcosis tested positive for cryptococcal antigen. Patients with concomitant extrapulmonary disease were more likely to have a positive antigen test result (P=.018), and antigen titers were higher in patients with extrapulmonary disease (P=.003) or fungemia (P=.045). Patients with single nodules were less likely to have a positive antigen test result than were those with all other radiographic presentations (P=.053). Among patients with isolated pulmonary cryptococcosis, lung transplant recipients were less likely to have positive cryptococcal antigen test results than were recipients of other types of SOT (P=.003). In all, 38% of the patients were asymptomatic or had pulmonary cryptococcosis detected as an incidental finding. Nodular densities or mass lesions were more likely to present as asymptomatic or incidentally detected pulmonary cryptococcosis than as pleural effusions and infiltrates (P=.008).
CONCLUSIONS: A positive serum cryptococcal antigen test result in SOT recipients with pulmonary cryptococcosis appears to reflect extrapulmonary or more advanced radiographic disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18171241      PMCID: PMC3395371          DOI: 10.1086/524738

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

1.  Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease.

Authors:  J A Aberg; J Watson; M Segal; L W Chang
Journal:  HIV Clin Trials       Date:  2000 Jul-Aug

2.  Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society.

Authors:  J H Austin; N L Müller; P J Friedman; D M Hansell; D P Naidich; M Remy-Jardin; W R Webb; E A Zerhouni
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

3.  Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

Authors:  P G Pappas; J R Perfect; G A Cloud; R A Larsen; G A Pankey; D J Lancaster; H Henderson; C A Kauffman; D W Haas; M Saccente; R J Hamill; M S Holloway; R M Warren; W E Dismukes
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

4.  Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary chinese hospital.

Authors:  Hongzhou Lu; Yingjie Zhou; Youkuan Yin; Xiaozhang Pan; Xinhua Weng
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Pulmonary cryptococcosis in patients without HIV infection.

Authors:  J A Aberg; L M Mundy; W G Powderly
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

6.  Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab.

Authors:  F P Silveira; S Husain; E J Kwak; P K Linden; A Marcos; R Shapiro; P Fontes; J W Marsh; M de Vera; K Tom; N Thai; H P Tan; A Basu; K Soltys; D L Paterson
Journal:  Transpl Infect Dis       Date:  2007-03       Impact factor: 2.228

7.  Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group.

Authors:  F Dromer; S Mathoulin; B Dupont; A Laporte
Journal:  Clin Infect Dis       Date:  1996-07       Impact factor: 9.079

Review 8.  Cryptococcosis in organ transplant recipients: an overview.

Authors:  Regis A Vilchez; John Fung; Shimon Kusne
Journal:  Am J Transplant       Date:  2002-08       Impact factor: 8.086

9.  Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat.

Authors:  D Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

Authors:  Françoise Dromer; Simone Mathoulin-Pélissier; Odile Launay; Olivier Lortholary
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

View more
  29 in total

Review 1.  Fungal diagnostics in pneumonia.

Authors:  Erika D Lease; Barbara D Alexander
Journal:  Semin Respir Crit Care Med       Date:  2011-12-13       Impact factor: 3.119

2.  Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans.

Authors:  Kerstin Voelz; David A Lammas; Robin C May
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

Review 3.  [Infections of the central nervous system in the immuno-compromised].

Authors:  E Schmutzhard; B Pfausler
Journal:  Nervenarzt       Date:  2008-09       Impact factor: 1.214

Review 4.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

5.  Clinical Significance of Low Serum Cryptococcal Antigen Titers by Lateral Flow Assay in Immunocompromised Patients: a Retrospective Case-Control Study.

Authors:  Erin Dizon; Wonjae Seo; Susan M Butler-Wu; Rosemary C She
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

6.  Update on Pulmonary Cryptococcosis.

Authors:  Deborah Yamamura; Jianping Xu
Journal:  Mycopathologia       Date:  2021-06-28       Impact factor: 2.574

Review 7.  Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.

Authors:  Judith A Anesi; John W Baddley
Journal:  Infect Dis Clin North Am       Date:  2015-12-28       Impact factor: 5.982

8.  Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease.

Authors:  J W Baddley; J R Perfect; R A Oster; R A Larsen; G A Pankey; H Henderson; D W Haas; C A Kauffman; R Patel; A K Zaas; P G Pappas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

9.  Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan.

Authors:  Kausik Datta; Andrew Lees; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2008-06-04

Review 10.  Cryptococcosis in solid organ transplant recipients: current state of the science.

Authors:  Nina Singh; Francoise Dromer; John R Perfect; Olivier Lortholary
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.